(Q58862004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Long-lasting cross-presentation of tumor antigen in human DC (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Adriana R Mantegazza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Christine Sedlik

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sebastian Amigorena

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Charlotte Sadaka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Francine Jotereau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

1 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

380-390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

The central role of CD4(+) T cells in the antitumor immune response

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Human T cell responses against melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Immunology. Licence to kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Dendritic cells: specialized and regulated antigen processing machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Pathways for antigen cross presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Cutting Edge: Intravenous Soluble Antigen Is Presented to CD4 T Cells by CD8- Dendritic Cells, but Cross-Presented to CD8 T Cells by CD8+ Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Differential antigen processing by dendritic cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

New tools for antigen delivery to the MHC class I pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Antigen loading of dendritic cells with whole tumor cell preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Part I: Vaccines for solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

21 January 2018

DC-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Antigen loading of MHC class I molecules in the endocytic tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

MHC class I-restricted exogenous presentation of a synthetic 102-mer malaria vaccine polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Dendritic cells in a mature age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Final antigenic Melan-A peptides produced directly by the proteasomes are preferentially selected for presentation by HLA-A*0201 in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Requirements for CD8 T-cell priming, memory generation and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Endocytosis mechanisms and the cell biology of antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100 209-217 and gp100 209-217T210M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

Exosomes: composition, biogenesis and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

inferred from DOI database lookup

7 January 2021

based on heuristic

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838669

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJI.200838669

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19130478%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference